Designed for in-training clinical fellows to learn about and apply Endocrine Society’s Clinical Practice Guidelines (CPGs), this activity explores the Pharmacological Treatment of Obesity guideline. By participating in this activity, fellows will be able to:

• Assess knowledge of pharmacological treatment of obesity
• Review the Endocrine Society CPG task force recommendations
• Review additional resources curated by task force member, Daniel Bessesen, MD of Denver Health Medical Center
• Submit a real or hypothetical clinical case for review
• Participate in an interactive webinar with expert faculty

Content covered by the CPG and this activity includes how providers can use medications as an adjunct to lifestyle change therapy to promote weight loss and maintenance. It also addresses how prescribers can prevent or attenuate weight gain when prescribing for diabetes, depression and chronic diseases often associated with obesity. The evidence review addresses medications with a weight loss indication, as well as those medications that have a weight effect when prescribed for a non-obesity indication i.e. that have been associated with significant weight gain and increase in risk of comorbidities or with weight loss.

Pharmacological Treatment of Obesity CPG Fellows Series is available to fellowship training programs subscribed to the Fellows Training Series.